Effectiveness, pharmacokinetics, and safety of a new sustained-release leuprolide acetate 3.75-mg depot formulation for testosterone suppression in patients with prostate cancer: A phase III, open-label, international multicenter study

✍ Scribed by Michael Marberger; Amir V Kaisary; Neal D. Shore; Gary S. Karlin; Claudio Savulsky; Ricard Mis; Chiara Leuratti; Josep R. Germa

• Book ID: 113544210
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 168 KB
• Volume: 32
• Category: Article
• ISSN: 0149-2918
• DOI: 10.1016/j.clinthera.2010.04.013